Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2022-04-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于2022年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 阳普医疗科技股份有限公司 regarding the expected daily related party transactions for the year 2022. It includes detailed information about the nature, estimated amounts, counterparties, and justifications for these related party transactions. The document also contains independent directors' opinions and supervisory board opinions on these transactions. There are no financial statements or comprehensive financial performance data presented, nor is this a full annual or interim report. The content focuses on disclosure of related party transactions, which is a regulatory requirement but does not constitute an audit report or financial report. This type of document is typically classified as a Regulatory Filing (RNS) because it is a regulatory announcement about related party transactions and does not fit into other specific categories such as Annual Report, Audit Report, or Management Reports.
2022-04-24 Chinese
关于召开2021年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of the 2021 annual performance explanation meeting (业绩说明会) for 阳普医疗科技股份有限公司. It references the 2021 annual report having been published on April 25, 2022, and invites investors to participate in an online meeting on April 29, 2022. The document does not contain the actual annual report or detailed financial data but serves as a notice for the upcoming investor presentation event. Given the content and length (835 characters), this fits the category of an Investor Presentation announcement rather than the report itself. Therefore, the appropriate classification is Investor Presentation (IP).
2022-04-24 Chinese
2021年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2021年度监事会工作报告" which translates to "2021 Supervisory Board Work Report". It details the supervisory board's activities, meetings, opinions on company operations, financial status, internal controls, related party transactions, and plans for 2022. It includes oversight and audit opinions but is not itself an audit report or annual report. The document is a formal report from the supervisory board on their work and oversight for the year, which is a type of management or supervisory report rather than a full annual report or audit report. It is not a short announcement or certification but a substantive report. Given the options, the closest category is "Management Reports (MDA)" which covers management's detailed explanation of financial results, business trends, and outlook, including supervisory board reports. Therefore, the document should be classified as MDA with high confidence.
2022-04-24 Chinese
独立董事2021年度述职报告（白华）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2021, detailing attendance at board and shareholder meetings, opinions on company matters, committee duties, investigations, investor protection efforts, and training. It is a narrative report on governance and director activities rather than a financial report, audit, or regulatory filing. It does not contain financial statements or earnings data, nor is it a brief announcement or proxy solicitation. The content aligns with Board/Management Information (MANG) as it relates to director duties and governance activities.
2022-04-24 Chinese
公司章程2022.04
Governance Information Classification · 100% confidence The document is titled as the "公司章程" (Company Articles of Association) of 阳普医疗科技股份有限公司 dated April 2022. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, voting procedures, and other governance-related rules. There is no indication that this is an annual report, financial statement, earnings release, or any other financial or regulatory filing. Instead, it is a governance document outlining the internal rules and regulations of the company. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), and it is not a mere announcement or certification, so it is not RPA or RNS.
2022-04-24 Chinese
独立董事2021年度述职报告（康熙雄）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2021 Annual Work Report" for Yangpu Medical Technology Co., Ltd. It details the independent director's attendance at board and shareholder meetings, opinions on various board proposals, committee duties, on-site investigations, investor protection efforts, training, and other work during the 2021 fiscal year. The content is a detailed report of the independent director's activities and responsibilities over the year, not a general annual report or financial statement. It is not a certification, announcement, or proxy solicitation. The document length is 3208 characters, which is relatively short but contains substantive content about management and board activities. This fits best under Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management. Therefore, the classification is MANG with high confidence.
2022-04-24 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.